Literature DB >> 5256403

Further studies on the role of circulating lymphocytes in the initiation of primary antibody responses to different antigens.

S Strober, L W Law.   

Abstract

Thoracic duct cells obtained from normal (unimmunized) donors restored the primary hemolysin response of lethally irradiated or neonatally thymectomized rats to sheep red blood cells. Synergy between thoracic duct cells and bone-marrow cells was demonstrated in the irradiated hosts. However, thoracic duct cells did not restore the primary antibody response of irradiated rats challenged with diphtheria toxoid, but did restore the response of neonatally thymectomized rats. The addition of peritoneal exudate cells or bone-marrow cells to inocula of thoracic duct cells also failed to restore the response of irradiated hosts to diphtheria toxoid, although normal spleen cells restored the response. These findings indicate that the cellular events involved in the initiation of the primary antibody response to sheep red blood cells differ from those involved in the response to diphtheria toxoid.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5256403      PMCID: PMC223608          DOI: 10.1073/pnas.62.4.1023

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  9 in total

1.  Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells.

Authors:  A B STAVITSKY
Journal:  J Immunol       Date:  1954-05       Impact factor: 5.422

2.  The role of lymphocytes in antibody formation. I. Restoration of the haemolysin response in x-irradiated rats with lymphocytes from normal and immunologically tolerant donors.

Authors:  D D McGregor; P J McCullagh; J L Gowans
Journal:  Proc R Soc Lond B Biol Sci       Date:  1967-09-12

3.  Initiation of primary antibody responses by both circulating and non-circulating lymphocytes.

Authors:  S Strober
Journal:  Nature       Date:  1968-08-10       Impact factor: 49.962

4.  Differences in the distribution of antigen reactive cells in the lymphoid tissues of the rat and mouse.

Authors:  S Strober; M A Mandel
Journal:  Proc Soc Exp Biol Med       Date:  1969-01

5.  Immunologic competence of thymectomized rats to several soluble and particulate antigens.

Authors:  J L Pinnas; F W Fitch
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes.

Authors:  G F Mitchell; J F Miller
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

7.  Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice.

Authors:  G J Nossal; A Cunningham; G F Mitchell; J F Miller
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

8.  Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes.

Authors:  J F Miller; G F Mitchell
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

9.  Studies on mouse leukaemia. The role of the thymus in leukaemogenesis by cell-free leukaemic filtrates.

Authors:  J F MILLER
Journal:  Br J Cancer       Date:  1960-03       Impact factor: 7.640

  9 in total
  2 in total

1.  Initiation of antibody responses by different classes of lymphocytes. IV. Lymphocytes involved in the primary antibody response to a hapten-protein conjugate.

Authors:  S Strober; L W Law
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

2.  Initiation of antibody responses by different classes of lymphocytes. I. Types of thoracic duct lymphocytes involved in primary antibody responses of rats.

Authors:  S Strober
Journal:  J Exp Med       Date:  1969-10-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.